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LIVER AND SMALL BOWEL TRANSPLANTATION 
FOR SHORT GUT SYNDROME 
IN A CHILD 
Case presented by: ANDREAS G. TZAKIS. SATORU TODO. JORGE REYES and THOMAS E. STARZL 
University of PIttsburgh 
Case discussed by: VIVIAN McAUSTER and DAVID GRANT 
University of Westem Ontario 
A 3 year old girl was referred to us for treatment of 
short gut syndrome and liver failure secondary to 
chronic ;rdminstration of total parenteral nutrition 
(TPN) 
Shortlv after birth. the child underwent resection of 
the small bowel distal to the ligament of Treitz and as-
cending colon for necrotizing enterocolitis and was 
placed on TPN. At the age of two years she developed 
hypersplenism for which she underwent splenectomy. 
Two months later she underwent cholecystectomy and 
common bile duct exploration for progressive jaundice. 
Other surgeries included a fundoplication at the age of 
two months and multiple TPN line placement and 
removal procedures. 
At the time of her referral to us she was jaundiced 
(total bilirubin 14 mg %) and had overt signs of portal 
hypertension including bleeding esophageal varices 
not controllable with sclerotherapy. 
An appropnate donor (Table 1) became available 
;rnd a combined liver and small intestinal transplant 
was performed. 
TABLE 1 
DONOR RECIPIENT 
Sex Female Female 
Age 31 months 38 months 
Weight 12 kg 12.4 kg 
Height 86cm 87cm 
ABO Type 0 0 
HLA Tvpe A2, 28, BS7, 60 A19, 24. B13, 
DR6, 7, BW4. 6 35,DRS.7. 
BW4.6 
CMV Status (+) c-) 
DONOR 
Supported bv research grants from the Veterans Administration 
;.md Project Grant No. DK 29961 from the Nationailnstitutes of 
Health. Bethesda. Maryland. Fig. 1. Composite liver-intestinal graft. 
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The donor operatton. The graft included the liver 
and entire small intestine distal to the ligament of Treitz 
and was procured using a modification of the "Flexible 
Procedure for Multiple Cadaveric Organ Procure-
ment."· The pancreas and duodenum were stripped off 
the SMV and SMA. An aortic patch containing the ostia 
of both celiac axis and SMA was included in the speci-
men (Fig. 1). Cooling of the graft was started in situ 
through the aorta and splenic vein and completed with 
·Surg Gynec Obstet 1984; 158: 223-30 
RECIPIENT 
Fig. 2. The recipient after hepatectomy. Note the end-ta-side 
ponaca val shunt onto the native vena cava which was preserved. 
a back table flush of the liver through the splenic vein 
cannula. UW solution was used at the preservation 
fluid. 
The recipientoperatton. The recipient operation was 
perfonned through a cruciate abdominal incision. After 
the hilar structures of the liver were identified, an end-
to-side portacaval shunt was perfonned and then a total 
hepatectomy with preservation of the native inferior 
vena cava (Fig. 2). 
The outflow of the graft was by an end-to-end anas-
tomosis of the donor suprahepatic cava onto the open-
ing created by joining the ostia of the left and middle 
hepatic veins. The right native hepatic vein was 
oversewn. The donor infra hepatic cava was ligated. The 
arterial patch with the celiac artery and SMA was im-
planted onto the infrarenal aorta of the recipient which 
was exposed after the duodenum had been Kocherised 
(Fig. 3). 
Mature stomata were created using the two ends of 
the intestinal graft. The distal end of the recipient duo-
denum was connected end-te-side to the graft. just 
below the proximal stoma. 
Biliary drainage was accomplished with a choledo-
che-jejunostomy into a Roux-en-Y loop created with 
donor jejunum. Complete GI continuity was established 
two months after transplant, at which time the proximal 
stoma was closed and the distal was connected to the 
colon (ileocolostomy) (Figs. 4 and 5). 
Immunosuppression. Immunosuppression was ac-
complished with FK506 which was given intravenously 
for four weeks and then orally---except peri operatively 
at the time of the closure of the stomata, at which time a 
short course of intravenous FK506 was administered. 
Prednisolone (10 mg/day) was given intravenously for 
eight days after transplantation. A single bolus of 500 
mg of hydrocortisone was given on the twenty-seventh 
TABLE 2 
PREVENlTON OF INFEcnON 
DONOR: Intestinal Decontamination, N.G.: 
Amphotericin 
Mycostatin 
Tobramycin 
Polymycin 
SYSTEMIC ANTIBIOTICS: 
Cefotaxime 
Ampicillin 
RECIPIENT:Intestinal Decontamination. P.O/N.G.: 
Mycostatin 
Tobramycin 
Amphotericin 
Polymycin 
II 
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postoperative day (POD) and again on PODs 34 and 48 
(Fig.6). 
Prevention and treatment of infection. Intestinal de-
contaminallon was performed for both donor and re-
cipient <Table 2). Only one dose could be given to the 
donor via a nasogastric tube. The recipient received 
intestinal decontamination for six months. Intravenous 
;,lnubiotics used for the treatment of bacteremias. which 
the pattent was found to have pretransplantation. were 
Fig. 3. Anastomosis to the recipient 
abdominal aorta and vena cava. 
continued The patient developed other bacteremias 
after transplantation which were also treated with intra-
venous antibiotics (Table 3). Cytomegalovirus (CMV) 
viremia and donor enteritis was detected at 3 112 
months and was treated with a 14 day course of DHPG. 
Biopsies. A liver biopsy performed at three months 
showed significant steatosis but no evidence of rejec-
tion. The biopsy was repeated at six months and showed 
evidence of mild rejection but not the previously noted 
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Fig. 4. UGI series after GI continuity was established. Note a 
barium cholangiogram from reflux into the Roux Y loop. 
April 1991 
Fig. 5. Endoscopic photograph of donor jejunum. 
fNFEcnON 
PRETRANSPLANf 
1. Catheter-associated bacteremia, POD 51 
2. Polymicrobial bacteremia, POD 5 
POSTfRANSPLANT 
1. Bacteremia, POD 15 
2. Enteritis, POD 30 
3. Bacteremia, POD 38 
4. Bacteremia, POD 47 
TABLE 3 
TREATMENT OF INFEcnON 
ORGANISM 
Staphylococcus aureus 
Staphylococcus aureus 
Eschericia coli 
Acinetobacter sp. 
Enterococcus sp. 
Cytomegalovirus 
Coagulase neg. Staph. 
Coagulase neg. Staph. 
'5. Bacteremia, POD 49 Streptococcus pneum. 
• Patient developed this infection while still on Vancomycin for treatement of pretransplant infection. 
TREATMENT 
Nafcillin IV 
Vancomycin IV 
Cefotaxime IV 
Vancomycin IV-
Ampicillin IV 
Vancomycin PO 
Ganciclovir IV 
Vancomycin IV 
Vancomycin IV# 
Vancomycin PO# 
Vancomycin IV# 
"Patient developed both of these episodes of bacteremia while receiving intravenous Vancomycin for treatment of infection number 
3. Oral Vancomycin was added when coagulase negative staphylOCOCCi were found in her stool. 
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Fig. 6. Liver and kidney function tests and immunosuppression. 
steatosis. 
Intestinal biopsies were obtained 8 days, .3 weeks 
and 3 112 months after transplantation. The first intes-
tinal biopsy showed a mixed infiltrate at the stroma 
which consisted of lymphocytes. eosinophils and some 
plasma cells with a distonion of the vtllous architecture. 
but the epithelium was intact. These changes resolved 
on subsequem biopsies (Fig. 7). The latter biopsy 
showed CMV inclusion bodies (not shown in figure). 
Fig. 7. Intestinal biopsy at.3 112 months. 
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Fig. 8. Percent of donor lymphocytes in A) peripheral blood and 
B) lamina propia of the intestinal graft. 
Immune monitortng. HLA phenotypes of lympho-
cytes from lamina propriae of the intestinal biopsies as 
well as peripheral blood smear were identified with 
immunocytochemical techniques employing monoclo-
nal amibodies. The results of these studies are shown in 
Figures 8A and 8B (by permission of Iwaki). 
Immune monitoring demonstrated a two way traf-
fic of lymphocytes between donor and recipient. which 
settled with the establishmem of recipient lymphocytes 
in the lamina propria of the intestinal graft and disap-
pearance of the donor lymphocytes from the peripheral 
blood of the recipient. 
Otber laboratory studies. CBC. electrolytes. BUN, 
serum creatinine. total bilirubin. SGOT. SGPT, alkaline 
phosphatase. serum albumin and globulin were fol-
lowed daily while the patient was in the hospital and 
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Fig. 9. D-xylose absorption study at three weeks posttransplan-
tation. 
once or twice weekly thereafter. Serum FK506 levels 
were obtained once or twice weekly. Representative 
values are shown in Fig. 6. 
Nutrition. Parenteral nutrition was maintained after 
transplantation. Starting at two weeks after transplanta-
tion. enteral feedings were given through the proximal 
stoma at increasing quantity and concentration. TPN 
was completely replaced by oral and enteral feedings at 
two months after transplantation. 
The patient's weight, 12.4 kg at the time of the trans-
plantation, is now-six months later-14 kg. Her 
height, 83 cm initially, is now 93 cm. 
A D-xylose absorption study at three weeks after 
transplantation via the central stoma was normal (Fig. 
9). Fecal fat excretion at four months was 8.85 (normal 0-
8.8%). 
Serum ferritin at 3 112 months after transplantation 
was 136 ng/ml (normal 12-250 ng/mi). 
Technical complications. Due to the large size of the 
graft. the fascia could not be safely approxlmated in the 
midline. Simple skin closure was performed which re-
sulted in dehiscence. The latter was treated with pack-
ing. The wound epithelialized, and the patient currently 
has a small midline incisional hernia. 
Clinical course. The postoperative course was com-
plicated by fevers which lasted for 1 1/2 months and for 
which several causes were elther suspected or identi-
fied. These included the previously described bactere-
mias. CMV infection. rejection and perhaps the lympho-
cytic mi~rationK 
The pauent was discharged from the hospital three 
months after transplantauon and has remained at home 
with the exception of short hospital stays for biopsies. 
Commentary 
Vivian McAlister and David Grant 
This case is a remarkable surgical achievement. It 
illustrates the potential for smail bowel and liver graft-
ing as a treatment of short gut syndrome in patients with 
or without liver failure. Isolated small bowel transplan-
tation has been unsuccessful due to the inability to 
control rejection. I Only two patients have have had 
prolonged intestinal graft survival and neither is free of 
parenteral support.2. 3 This is the second report of suc-
cessful smail bowel and liver grafting and the first 
report of this procedure in a child. Successful combined 
small bowel and liver transplants were performed in 
two adults at our institution 18 and 30 months agoK~ Like 
the case reported here, these patients are on regular 
diets and they require no parenteral support. Three 
questions raised by this experience are reviewed below. 
What is the best surgical procedure for transplant-
ing the small bowel and liver together? The abdommal 
cavity may be very smail in patients that have had 
massive intestinal resecions. To avoid problems with 
size discrepancies as reported in this case. the smail 
intestine/liver graft should probably be obtained from 
a donor 30-50 percent smaller than the recipient. The 
piggy-back technique described by Tzakis and col-
leagues allows transplant surgeons to easily manage 
large size differences of the donor and recipient vena 
cava. Creation of a portacaval shunt prior to the trans-
plant maintains venous return from the native gastroin-
testinal tract during the anhepatic phase of the 
operation without the need for venovenous bypass. 
However, this technique deprives the transplanted liver 
of hepatotrophic substances from the native pancreas. 
So we have preferred to anastomose the end of the 
native portal vein to the side of the intact donor portal 
vein." 
Exteriorization of both ends of the intestinal graft as 
described in this case may be unnecessary. More than ;0 
small bowel transplants were performed in our labora-
tory in pigs with no leakage from primary mtestinal 
anastomoses. 5 Anastomosis of the proximal end of the 
intestinal graft to the native gastrointestinal tract may 
optimize graft function by exposing the transplanted 
gut to the nutrient factors in the succus entericus. Crea-
tion of a distal stoma provides an easy route to biopsy 
the graft. However. in our experience. mucosal biopsies 
are unreliable for the early detection of rejection due to 
the patchy nature of the this process." 
Does the liver contribute to small bowel allograft 
survival by enhancing immunosuppresion and toler-
:mce? The Immunosuppressive effects of liver trans-
.. 
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plantation have been demonstrated in both animals and 
humans. Liver grafting produces clonal deletion of 
cytotoxic T cells,7 enhancement of anti-class II MHC 
antibodies 7 and release of soluble donor immunosup-
pressive class I antigens. II Long term hepatic graft sur-
vival without immunosuppression is commonly seen in 
the pig and in certain inbred rat strains whereas other 
organs such as skin. heart and kidney are acutely re-
jected.7. 9 In these animals, simultaneous liver grafting 
induces a state of donor specific unresponsiveness 
which permits transplantation of skin. heart and kidney 
grafts without immunosuppression. II. 10 Similar effects 
may occur in man. Fung et al have reported that simul-
taneous liver transplantation permits successful kidney 
transplantation in patients with preformed cytotoxic 
Jntibodies. l1 Gonwa et al have reported a much lower 
fate of kidney rejection in patients with simultaneous 
liver grafts. 12 
Whether simultaneous liver grafting protects the 
intestmal graft from relection is still unclear. We have re-
cently demonstrated that simultaneous liver transplan-
tation prevents intestinal allograft rejection in a low-re-
sponder rat strain combination. However. many of the 
animals in this study died of graft-versus-host disease. 
13 Another study using a high-responder rat strain com-
bination and a multivisceral transplant model showed 
that simultaneous liver grafting did not protect the 
intestinal allograft from relection.14 Further experi-
ments are needed to clarify the complex immunological 
responses associated with multivisceral grafting. 
Why is sepsis so common after intestinal grafting? 
This patient had many infections as did the patients that 
were transplanted at our institution. Small bowel and 
liver reCipients may require less immunosuppression 
[han usual. IS The reduced need for anti rejection therapy 
may he due to the immunosuppressive effects of 
simuiltaneous liver grafting as described above. Alter-
natively. host immune defenses may be compromised 
by occult graft-versus-host disease caused by the large 
numbers of lymphocytes in the combined graft. 16 Fi-
nally, bacterial translocation from the rejecting intesti-
nal allograft may contribute to host infections after 
small bowel transplantation. I" 
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